You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRD4

Showing 1 - 25 of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

Not yet recruiting
  • Advanced Uveal Melanoma
  • +2 more
  • BRD4 Inhibitor PLX2853
  • +4 more
  • (no location specified)
Jan 9, 2023

Acute GVHD, Steroid Refractory GVHD Trial in Columbus (BRD4 Inhibitor PLX51107)

Recruiting
  • Acute Graft Versus Host Disease
  • Steroid Refractory Graft Versus Host Disease
  • BRD4 Inhibitor PLX51107
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 24, 2022

Pulmonary Arterial Hypertension Trial in Calgary, Quebec City (Apabetalone)

Completed
  • Pulmonary Arterial Hypertension
  • Calgary, Alberta, Canada
  • +1 more
Apr 22, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Trial in Houston (Azacitidine, BRD4

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 19, 2020

Solid Tumor, Childhood, Lymphoma, Brain Tumor, Pediatric Trial in Canada, United States (BMS-986158, BMS-986378)

Recruiting
  • Solid Tumor, Childhood
  • +2 more
  • Boston, Massachusetts
  • +5 more
Dec 27, 2022

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor, Recurrent Platinum-Resistant Ovarian Carcinoma Trial in

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • +3 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • Bethesda, Maryland
  • +4 more
Aug 16, 2022

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Healthy Volonteers Trial in Saint-Étienne (behavioral, device, biological, other)

Not yet recruiting
  • Healthy Volonteers
  • On-duty Nap
  • +14 more
  • Saint-Étienne, France
    Chu de Saint-Etienne
Jul 19, 2023

Advanced Solid Tumors Trial in Tianjin (Drug: SYHA1801)

Recruiting
  • Advanced Solid Tumors
  • Drug: SYHA1801
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital
Jun 4, 2020

Metastatic NUT Carcinoma, Unresectable NUT Carcinoma Trial (Cisplatin, Etoposide, Etoposide Phosphate)

Withdrawn
  • Metastatic NUT Carcinoma
  • Unresectable NUT Carcinoma
  • (no location specified)
Sep 25, 2020

MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

Not yet recruiting
  • MPNST
  • +2 more
  • Birmingham, Alabama
  • +13 more
Jun 29, 2022

Synovial Sarcoma, Soft Tissue Sarcoma Trial in United States (CFT8634)

Recruiting
  • Synovial Sarcoma
  • Soft Tissue Sarcoma
  • Duarte, California
  • +12 more
Feb 2, 2023

Pathogenic Bordetella Rapid Detection

Withdrawn
  • Pertussis
  • Detection pathogenic pertussis by cross primer constant temperature amplification (CPA) and drug resistant genes of erythromycin by CRISPR technology
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
Sep 13, 2022

SLE Trial in Worldwide (ESK-001, Placebo)

Recruiting
  • SLE
  • Anniston, Alabama
  • +138 more
Jul 21, 2023

Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

Terminated
  • Serologically Active Adult Systemic Lupus Erythematosus
  • Autologous EBV specific CTL infusion
  • Nantes, France
  • +2 more
Mar 24, 2022

Hepatocellular Carcinoma Trial in France (TACE, TACE+ RTC)

Completed
  • Hepatocellular Carcinoma
  • TACE
  • TACE+ RTC
  • Amiens, France
  • +17 more
Dec 23, 2021

Anti-BK Virus Immune Response and Kidney Transplantation

Completed
  • Kidney Transplantation
  • biological parameters
  • Nantes, France
    Nantes' Univeristy hospital
Sep 13, 2021

Arthritis, Rheumatoid Trial in Worldwide (Otilimab (GSK3196165), csDMARD(s))

Active, not recruiting
  • Arthritis, Rheumatoid
  • Anniston, Alabama
  • +382 more
Jan 24, 2023

Relevance of Plasma PCSK9 Concentration asBiomarker in Acute

Completed
  • Acute Coronary Syndrome
  • biological parameters dosage
  • Nantes, France
  • +1 more
Sep 13, 2021

Breast Milk on the Neurodevelopment of Preterm Newborns

Active, not recruiting
  • Prematurity of Fetus
  • Physiopathology
  • Nantes, France
    University Hospital of Nantes
Jul 20, 2021

Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

Recruiting
  • Sarcoma,Soft Tissue
  • Tenerife, Canarias, Spain
  • +10 more
Oct 27, 2023

Rheumatoid Arthritis Trial in Worldwide (M2591 25 mg QD, M2951 75 mg QD, M2951 50 mg BID)

Completed
Has Results
  • Rheumatoid Arthritis
  • M2591 25 mg QD
  • +3 more
  • Phoenix, Arizona
  • +97 more
Sep 4, 2020

Rheumatoid Arthritis Trial in Worldwide (Olokizumab 64mg q4w, Olokizumab 64mg q2w, Adalimumab 40mg q2w)

Completed
Has Results
  • Rheumatoid Arthritis
  • Olokizumab 64mg q4w
  • +3 more
  • Mesa, Arizona
  • +244 more
Apr 6, 2021

Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)

Active, not recruiting
  • Head and Neck Cancer
  • recombinant thyroid-stimulating hormone
  • Radiodine ablation without rhTSH
  • Brighton, England, United Kingdom
  • +24 more
Oct 13, 2021